Gerald Hladik is a Nephrology physician affiliated with University of North Carolina at Chapel Hill. OpenAlex indexes 31 publications with 982 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
7008 Burnett Womack
Campus Box 7155
Chapel Hill, NC 275990001
Telephone
919-966-2561Registry record last updated 8 Jul 2007.
Industry payments
3 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Otsuka America Pharmaceutical, Inc.Program year20231 payment
- Alexion Pharmaceuticals, Inc.Program year20231 payment
- Otsuka America Pharmaceutical, Inc.Program year20221 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cardiovascular
54.6%Angiotensin receptor blocker (ARB)11.3%Telmisartan50%Losartan Potassium28%Valsartan21%Part D≥24 patientsCalcium channel blocker10.4%Amlodipine Besylate91%Nifedipine Er10%Part D<11 patients+ 12 more classes in this area
Metabolism & gastrointestinal
13.8%Proton pump inhibitor3.3%Omeprazole100%Part D≥13 patientsCorticosteroid3%Prednisone100%Part D≥16 patients+ 4 more classes in this area
Nervous system
13.4%Opioid Agonist3.8%Tramadol Hcl53%Oxycodone Hcl47%Part D<11 patientsSSRI3.2%Sertraline Hcl53%Trazodone Hcl47%Part D<11 patients+ 4 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 1999–2002 per NIH RePORTER. The latest:
- AMG 073 IN SECONDARY HYPERPARATHYROIDISM
University of North Carolina Chapel Hill
FY2002$190,747M01RR000046 - AMG 073 IN SECONDARY HYPERPARATHYROIDISM
University of North Carolina Chapel Hill
FY2001$294,555M01RR000046 - AMG 073 IN SECONDARY HYPERPARATHYROIDISM
University of North Carolina Chapel Hill
FY2001$190,747M01RR000046
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Legion of Inflammation: Legionella-Induced Nephritis
Journal of the American Society of Nephrology
2025 - Native BK Virus Nephropathy in a Patient with Multiple Myeloma
Journal of the American Society of Nephrology
2024 - Supportive Care and Symptom Management for Patients With Immunoglobulin Light Chain (AL) Amyloidosis
Frontiers in Oncology
2022
Similar KOLs
Other experts from the same institution or the same specialty.
Lisa Carey, MD
University of North Carolina at Chapel Hill
Robert Sandler, MD
University of North Carolina at Chapel Hill
Diana Perkins, MD
University of North Carolina at Chapel Hill
Hyman Muss, MD
University of North Carolina at Chapel Hill
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”